Related Topics
     

    Gilbertson: News Releases & Feature Stories

     
    11/03/2014
    St. Jude Children’s Research Hospital appoints scientific director

    Richard Gilbertson, M.D., Ph.D., to direct scientific enterprise for the institution

     
     
    02/19/2014
    Gene sequencing project discovers common driver of a childhood brain tumor

    St. Jude Children’s Research Hospital -Washington University Pediatric Cancer Genome Project identifies the most common genetic alteration yet in the brain tumor ependymoma; results offer clues for fighting other cancers. (Richard Gilbertson, MD, PhD, David Ellison, MD, PhD, Jinghui Zhang, PhD)

     
     
    02/19/2014
    Brain tumor culprit caught

    A hunt through billions of pieces of genetic information uncovers new clues on treatments for childhood ependymoma.

     
     
    09/19/2012
    Solving the Puzzle

    Scientists explore subtypes of a deadly brain tumor.

     
     
    06/20/2012
    Gene sequencing project identifies potential drug targets in common childhood brain tumor

    St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project lifts lid on the most aggressive subtype of medulloblastoma and finds genes that cooperate in tumor development. (Dr. Richard Gilbertson)

     
     
    01/12/2012
    Writing the Next Chapter

    For many years, St. Jude researchers have been investigating the connection between genetics and pediatric cancer. Those approaches continue to have dramatic implications for clinical care.

     
     
    09/15/2011
    New strategy likely to speed drug development for rare cancers

    Research led by St. Jude Children’s Research Hospital investigators used a pioneering approach to drug development and identified dozens of potential new treatments of ependymoma, a rare tumor of the brain and spinal cord.

     
     
    08/19/2011
    St. Jude Children's Research Hospital appoints Richard Gilbertson, M.D., Ph.D., to lead its Comprehensive Cancer Center

    Noted researcher will direct the country's only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children.

     
     
    12/08/2010
    Different origins discovered for medulloblastoma tumor subtypes

    International effort led by St. Jude Children’s Research Hospital scientists is expected to fuel development of targeted therapies and aid the search for unique combinations of cells and mutations that lead to other cancers

     
     
    07/20/2010
    St. Jude scientists develop new genomics-based approach to understand the origin of cancer subgroups

    Scientists have long recognized that cancers may look the same under the microscope, but carry different mutations, respond differently to treatment and result in vastly different outcomes for patients.

     
     
    12/30/2008
    Molecular marker identifies normal stem cells as intestinal tumor source

    St. Jude scientists have answered a central question in cancer biology: whether normal stem cells can give rise to tumors.

     
     
    03/31/2008
    Coming to the table for discovery

    Whenever family and friends are invited to your home, chances are the evening will end with everyone lingering in the kitchen. Perhaps someone has a warm pot of coffee to share, a story or a hearty laugh. Whatever the attraction, the heart of the home beats strongest when everyone joins together. At St. Jude Children’s Research Hospital, the Chemical Biology and Therapeutics (CBT) department serves a similar role.

     
     
    03/16/2007
    Gilbertson receives support for brain tumor research

    Richard Gilbertson, MD, PhD, has received almost $1 million in support from two foundations that support brain tumor research.

     
     
    01/24/2007
    Brain tumor researchers find their "niche"

    St. Jude researchers have found a vulnerable spot in brain tumors they are trying to exploit to improve the treatment of these cancers and prevent tumors from returning.

     
     
    08/18/2006
    Tumor Wars

    St. Jude researchers launch a counterattack on pediatric cancer using molecular-targeted therapy. As scientists learn more about the human genome and specific genetic mutations, they are finding new strategies to ambush the enemy.

     
     
    05/10/2006
    Powerful new tool for studying brain development

    The mouse Brain Gene Expression Map at St. Jude shows where and when genes influence development of the brain and helps researchers study links between gene mutations and cancers.

     
     
    04/17/2006
    Technique could speed new treatments for medulloblastoma

    The discovery that expression of specific genes can accurately report the presence of mutations in biochemical pathways within medulloblastoma cells could speed development of more effective and less toxic treatments.

     
     
    02/20/2006
    Touchdown: Neurobiology and Brain Tumor Program

    Thanks to the St. Jude Neurobiology and Brain Tumor Program, victory is within reach for kids with medulloblastoma.

     
     
    11/14/2005
    Discovery may mean better ependymoma treatments

    Ependymomas that occur in different parts of the central nervous system appear to arise from different subpopulations of stem cells. The discovery explains why some identical-looking ependymomas are actually distinctly different diseases...

     
     
    03/02/2004
    Improving treatment of medulloblastoma

    Clinical researchers are getting closer to an international clinical trial to improve guidelines for treatment of medulloblastoma.